1. Home
  2. CING vs INBS Comparison

CING vs INBS Comparison

Compare CING & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • INBS
  • Stock Information
  • Founded
  • CING 2012
  • INBS 2016
  • Country
  • CING United States
  • INBS United States
  • Employees
  • CING N/A
  • INBS N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • INBS Medical Specialities
  • Sector
  • CING Health Care
  • INBS Health Care
  • Exchange
  • CING Nasdaq
  • INBS Nasdaq
  • Market Cap
  • CING 14.4M
  • INBS 12.3M
  • IPO Year
  • CING 2021
  • INBS N/A
  • Fundamental
  • Price
  • CING $4.27
  • INBS $2.21
  • Analyst Decision
  • CING Strong Buy
  • INBS
  • Analyst Count
  • CING 3
  • INBS 0
  • Target Price
  • CING $16.00
  • INBS N/A
  • AVG Volume (30 Days)
  • CING 118.1K
  • INBS 394.6K
  • Earning Date
  • CING 03-31-2025
  • INBS 02-13-2025
  • Dividend Yield
  • CING N/A
  • INBS N/A
  • EPS Growth
  • CING N/A
  • INBS N/A
  • EPS
  • CING N/A
  • INBS N/A
  • Revenue
  • CING N/A
  • INBS $3,031,405.00
  • Revenue This Year
  • CING N/A
  • INBS $280.88
  • Revenue Next Year
  • CING N/A
  • INBS $126.26
  • P/E Ratio
  • CING N/A
  • INBS N/A
  • Revenue Growth
  • CING N/A
  • INBS 23.21
  • 52 Week Low
  • CING $1.80
  • INBS $1.00
  • 52 Week High
  • CING $20.83
  • INBS $5.63
  • Technical
  • Relative Strength Index (RSI)
  • CING 42.05
  • INBS 57.70
  • Support Level
  • CING $4.22
  • INBS $2.04
  • Resistance Level
  • CING $4.58
  • INBS $2.75
  • Average True Range (ATR)
  • CING 0.32
  • INBS 0.27
  • MACD
  • CING -0.04
  • INBS 0.02
  • Stochastic Oscillator
  • CING 12.64
  • INBS 51.79

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).

Share on Social Networks: